Latest News

S1 Biopharma are at it again and about to begin phase 2b trials for their latest offering, a combination of two drugs that are already approved for the treatment of depression, now to be used together as a combined therapy for the treatment of female sexual dysfunction (FSD)...

With so little in the UK/EU pipeline in terms of weight loss treatments, there is a great focus now on the phase III trials of Beloranib, a prospective obesity drug made by Zafgen...

Contrave has been approved for prescription in the United States...

The relationship between vitamin D and asthma has been receiving increasing attention in the scientific community...

The increase of allergies is a growing problem across the UK and it is estimated that one in three suffers from some of the most common allergies...